Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples